Kathy Gratton

544 total citations
23 papers, 423 citations indexed

About

Kathy Gratton is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kathy Gratton has authored 23 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Hematology. Recurrent topics in Kathy Gratton's work include Multiple Myeloma Research and Treatments (6 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (4 papers). Kathy Gratton is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (4 papers). Kathy Gratton collaborates with scholars based in Canada, United States and Italy. Kathy Gratton's co-authors include Douglas A. Stewart, Nizar J. Bahlis, Paola Neri, Peter Duggan, Adnan Mansoor, Li Ren, Alexander C. Klimowicz, Pierfrancesco Tassone, Lawrence Boise and Ahmed Mostafa and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Kathy Gratton

22 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Gratton Canada 8 296 167 167 83 55 23 423
Bon Ham Yip United Kingdom 13 568 1.9× 96 0.6× 221 1.3× 145 1.7× 51 0.9× 17 704
Tomas Bos Belgium 13 424 1.4× 174 1.0× 62 0.4× 107 1.3× 187 3.4× 16 659
Umberto Torelli Italy 14 256 0.9× 76 0.5× 196 1.2× 35 0.4× 101 1.8× 38 506
Michael Nawrath Switzerland 15 291 1.0× 125 0.7× 33 0.2× 85 1.0× 199 3.6× 23 544
Melisa Ruiz‐Gutierrez United States 9 742 2.5× 84 0.5× 55 0.3× 81 1.0× 92 1.7× 12 845
Toon F.C.M. Smetsers Netherlands 15 335 1.1× 104 0.6× 280 1.7× 59 0.7× 125 2.3× 21 654
Moon Gyo Kim South Korea 12 247 0.8× 87 0.5× 53 0.3× 29 0.3× 85 1.5× 23 442
Claudia Lange Germany 9 216 0.7× 78 0.5× 49 0.3× 150 1.8× 45 0.8× 13 333
Jutta Friel Germany 11 480 1.6× 112 0.7× 204 1.2× 224 2.7× 135 2.5× 20 663
Tamara Tripic United States 6 335 1.1× 221 1.3× 89 0.5× 103 1.2× 163 3.0× 9 596

Countries citing papers authored by Kathy Gratton

Since Specialization
Citations

This map shows the geographic impact of Kathy Gratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Gratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Gratton more than expected).

Fields of papers citing papers by Kathy Gratton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Gratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Gratton. The network helps show where Kathy Gratton may publish in the future.

Co-authorship network of co-authors of Kathy Gratton

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Gratton. A scholar is included among the top collaborators of Kathy Gratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Gratton. Kathy Gratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thirukkumaran, Chandini M., Zhong Qiao Shi, Gerard J. Nuovo, et al.. (2019). Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model. Blood Advances. 3(5). 797–812. 20 indexed citations
2.
Mostafa, Ahmed, Daniel E. Meyers, Chandini M. Thirukkumaran, et al.. (2018). Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer. Cancers. 10(6). 205–205. 43 indexed citations
3.
Lawson, Keith A., Ahmed Mostafa, Zhong Qiao Shi, et al.. (2016). Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma. Clinical Cancer Research. 22(23). 5839–5850. 31 indexed citations
4.
Mostafa, Ahmed, et al.. (2015). Abstract A12: PDL-1 blockade and Sunitinib enhance the efficiency of oncolytic viral therapy. Cancer Immunology Research. 3(10_Supplement). A12–A12. 2 indexed citations
5.
Neri, Paola, et al.. (2013). XPO1 Inhibition Disrupts Ribosomal Subunits Assembly and Induces Multiple Myeloma (MM) Cell Death. Blood. 122(21). 3165–3165. 5 indexed citations
6.
7.
Klimowicz, Alexander C., Paola Neri, Andrew Belch, et al.. (2012). High Cereblon Protein Expression Correlates with Improved Response and Survival in Myeloma Patients Treated with Lenalidomide. Blood. 120(21). 931–931. 9 indexed citations
8.
Neri, Paola, Peter Duggan, Kathy Gratton, et al.. (2012). Phase I Study of the PARP1-2 Inhibitor Veliparib in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 120(21). 1862–1862. 3 indexed citations
9.
Slabý, Jiří, Paola Neri, Kathy Gratton, et al.. (2012). Lenalidomide Suppresses 5′-Cap-Independent C-MYC Translation in Multiple Myeloma Cells. Blood. 120(21). 3943–3943. 1 indexed citations
10.
Neri, Paola, Andrew R. Belch, Kathy Gratton, et al.. (2011). A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients. Blood. 118(21). 987–987. 3 indexed citations
11.
Neri, Paola, et al.. (2011). Mir-34a Sensitizes Multiple Myeloma (MM) Cells to the Proteasome Inhibitor Bortezomib. Blood. 118(21). 138–138. 4 indexed citations
12.
Neri, Paola, Li Ren, Kathy Gratton, et al.. (2010). Bortezomib Induced BRCAness Sensitizes Multiple Myeloma Cells to PARP Inhibitors. Blood. 116(21). 789–789. 1 indexed citations
13.
Neri, Paola, Kathy Gratton, Adnan Mansoor, et al.. (2009). miRNA Expression in Multiple Myeloma as Predictive Model of Response to Bortezomib.. Blood. 114(22). 4918–4918. 7 indexed citations
14.
Neri, Paola, Li Ren, Kathy Gratton, et al.. (2009). Integrin β7-Mediated Regulation of Multiple Myeloma Cell Adhesion, Migration and Survival.. Blood. 114(22). 949–949. 1 indexed citations
15.
Gratton, Kathy, Doug Demetrick, Pau Serra, et al.. (2009). Spontaneous Autoimmunity Sufficiently Potent to Induce Diabetes Mellitus Is Insufficient to Protect against Insulinoma. The Journal of Immunology. 183(3). 1705–1714. 1 indexed citations
16.
Grassi, Claudio, et al.. (2007). P54. Journal of Surgical Research. 137(2). 260–260. 1 indexed citations
17.
Bahlis, Nizar J., et al.. (2005). PKC δ Inhibition Restores PTEN Activity in Myeloma Cells and Prolongs Survival of GFP+ Myeloma SCID/NOD Mice In Vivo.. Blood. 106(11). 113–113. 1 indexed citations
18.
Bech‐Hansen, N. Torben, et al.. (1998). Localization of a gene for incomplete X-linked congenital stationary night blindness to the interval between DXS6849 and DXS8023 in Xp11.23. Human Genetics. 103(2). 124–130. 30 indexed citations
19.
Boycott, Kym M., et al.. (1997). Integration of 101 DNA markers across human Xp11 using a panel of somatic cell hybrids. Cytogenetic and Genome Research. 76(3-4). 223–228. 7 indexed citations
20.
Boycott, Kym M., Kathy Gratton, & B. J. Moore. (1994). Development of a YAC contig covering the minimal region of a CSNB1 locus in Xp11. The American Journal of Human Genetics. 55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bon Ham Yip Breakdown of academic impact, for papers by Tomas Bos Breakdown of academic impact, for papers by Umberto Torelli Breakdown of academic impact, for papers by Michael Nawrath Breakdown of academic impact, for papers by Melisa Ruiz‐Gutierrez Breakdown of academic impact, for papers by Toon F.C.M. Smetsers Breakdown of academic impact, for papers by Moon Gyo Kim Breakdown of academic impact, for papers by Claudia Lange Breakdown of academic impact, for papers by Jutta Friel Breakdown of academic impact, for papers by Tamara Tripic
Rankless by CCL
2026